Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares OutstandingShares Outstanding
Ratios

Relay Therapeutics (RLAY) Other Gross PP&E Adjustments (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$32.4 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 4.3% to -$32.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$32.4 million through Dec 2025, up 4.3% year-over-year, with the annual reading at -$32.4 million for FY2025, 4.3% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$32.4 million at Relay Therapeutics, up from -$41.6 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was -$8.2 million in Q4 2021, with the low at -$65.2 million in Q3 2022.
  • Average Other Gross PP&E Adjustments over 5 years is -$42.1 million, with a median of -$46.2 million recorded in 2025.
  • The sharpest move saw Other Gross PP&E Adjustments crashed 485.16% in 2022, then rose 22.09% in 2025.
  • Over 5 years, Other Gross PP&E Adjustments stood at -$8.2 million in 2021, then plummeted by 485.16% to -$48.2 million in 2022, then rose by 11.0% to -$42.9 million in 2023, then increased by 21.2% to -$33.8 million in 2024, then increased by 4.3% to -$32.4 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$32.4 million, -$41.6 million, and -$46.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.